• Często zadawane pytania
  • Słownik
Więcej

Często zadawane pytania

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Zobacz wszystkie często zadawane pytania

Więcej

Słownik

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

Zobacz kompletny słowniczek

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
    Showing 3 of 168 results.
    Page 34 of 34
    2021

    Patient and Public Involvement

    Toolkit of resources published by the Blood and Transplant Research Unit in Donor Health and Genomics at University of Cambridge
    Visit this Resource

    Research Field

    • General

    Organisation Type

    • Funder
    • Academia

    Development Stage

    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • UK

    Content Type

    • Resource
    2020

    NHS Readiness toolkit

    Toolkit of resources developed by the Advanced Therapy Treatment Centre (ATTC)
    Visit this Resource

    Research Field

    • ATMP/Gene Therapy Development

    Organisation Type

    • Healthcare
    • Other Organisation

    Development Stage

    • Service Delivery

    Audience

    • Other groups

    Country

    • UK

    Content Type

    • Resource
    2021

    What is Public and Patient Involvement

    Toolkit of resources published by the Alzheimers Society
    Visit this Resource

    Research Field

    • General

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • UK

    Content Type

    • Resource
    Powrót do góry strony